Inventiva S.A. (EPA:IVA)
France · Delayed Price · Currency is EUR 4.625
-0.150 (-3.14%)
Apr 21, 2026, 5:15 PM CET
Inventiva Market Cap
Inventiva has a market cap or net worth of €991.8 million as of April 21, 2026. Its market cap has increased by 277.01% in one year.
Market Cap
991.80M
Enterprise Value
1.12B
Revenue
6.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.63
Market Cap Chart
Since February 15, 2017, Inventiva's market cap has increased from 134.55M to 991.80M, an increase of 637.15%. That is a compound annual growth rate of 24.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 991.80M | 31.60% |
| Dec 31, 2025 | 753.62M | 261.37% |
| Dec 31, 2024 | 208.54M | -1.39% |
| Dec 29, 2023 | 211.49M | 12.21% |
| Dec 30, 2022 | 188.49M | -60.71% |
| Dec 31, 2021 | 479.69M | 6.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 8.29B |
| Nanobiotix | 1.39B |
| DBV Technologies | 1.07B |
| MedinCell | 871.03M |
| Genfit | 457.12M |
| Valneva SE | 450.19M |
| Cellectis | 274.54M |
| Transgene | 211.16M |